Global Semi-Solid Dose Market Growth 2025-2031
The global Semi-Solid Dose market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
United States market for Semi-Solid Dose is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Semi-Solid Dose is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Semi-Solid Dose is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Semi-Solid Dose players cover Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Semi-Solid Dose Industry Forecast” looks at past sales and reviews total world Semi-Solid Dose sales in 2024, providing a comprehensive analysis by region and market sector of projected Semi-Solid Dose sales for 2025 through 2031. With Semi-Solid Dose sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Semi-Solid Dose industry.
This Insight Report provides a comprehensive analysis of the global Semi-Solid Dose landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Semi-Solid Dose portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Semi-Solid Dose market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Semi-Solid Dose and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Semi-Solid Dose.
This report presents a comprehensive overview, market shares, and growth opportunities of Semi-Solid Dose market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Semi-Solid Dose market?
What factors are driving Semi-Solid Dose market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Semi-Solid Dose market opportunities vary by end market size?
How does Semi-Solid Dose break out by Type, by Application?
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
United States market for Semi-Solid Dose is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Semi-Solid Dose is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Semi-Solid Dose is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Semi-Solid Dose players cover Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Semi-Solid Dose Industry Forecast” looks at past sales and reviews total world Semi-Solid Dose sales in 2024, providing a comprehensive analysis by region and market sector of projected Semi-Solid Dose sales for 2025 through 2031. With Semi-Solid Dose sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Semi-Solid Dose industry.
This Insight Report provides a comprehensive analysis of the global Semi-Solid Dose landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Semi-Solid Dose portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Semi-Solid Dose market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Semi-Solid Dose and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Semi-Solid Dose.
This report presents a comprehensive overview, market shares, and growth opportunities of Semi-Solid Dose market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Ointments
- Pastes
- Gels
- Skin
- Nasal Cavity
- Vaginal Cavity
- Rectal Cavity
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Merck & Co
- Bayer AG
- Hisamitsu Pharmaceutical
- Glenmark Pharmaceuticals
- Cipla Ltd
- Nestle SA
- Novartis AG
- GlaxoSmithKline plc
- Bausch Health Companies
What is the 10-year outlook for the global Semi-Solid Dose market?
What factors are driving Semi-Solid Dose market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Semi-Solid Dose market opportunities vary by end market size?
How does Semi-Solid Dose break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Semi-Solid Dose Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Semi-Solid Dose by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Semi-Solid Dose by Country/Region, 2020, 2024 & 2031
2.2 Semi-Solid Dose Segment by Type
2.2.1 Ointments
2.2.2 Pastes
2.2.3 Gels
2.3 Semi-Solid Dose Sales by Type
2.3.1 Global Semi-Solid Dose Sales Market Share by Type (2020-2025)
2.3.2 Global Semi-Solid Dose Revenue and Market Share by Type (2020-2025)
2.3.3 Global Semi-Solid Dose Sale Price by Type (2020-2025)
2.4 Semi-Solid Dose Segment by Application
2.4.1 Skin
2.4.2 Nasal Cavity
2.4.3 Vaginal Cavity
2.4.4 Rectal Cavity
2.4.5 Others
2.5 Semi-Solid Dose Sales by Application
2.5.1 Global Semi-Solid Dose Sale Market Share by Application (2020-2025)
2.5.2 Global Semi-Solid Dose Revenue and Market Share by Application (2020-2025)
2.5.3 Global Semi-Solid Dose Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Semi-Solid Dose Breakdown Data by Company
3.1.1 Global Semi-Solid Dose Annual Sales by Company (2020-2025)
3.1.2 Global Semi-Solid Dose Sales Market Share by Company (2020-2025)
3.2 Global Semi-Solid Dose Annual Revenue by Company (2020-2025)
3.2.1 Global Semi-Solid Dose Revenue by Company (2020-2025)
3.2.2 Global Semi-Solid Dose Revenue Market Share by Company (2020-2025)
3.3 Global Semi-Solid Dose Sale Price by Company
3.4 Key Manufacturers Semi-Solid Dose Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Semi-Solid Dose Product Location Distribution
3.4.2 Players Semi-Solid Dose Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SEMI-SOLID DOSE BY GEOGRAPHIC REGION
4.1 World Historic Semi-Solid Dose Market Size by Geographic Region (2020-2025)
4.1.1 Global Semi-Solid Dose Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Semi-Solid Dose Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Semi-Solid Dose Market Size by Country/Region (2020-2025)
4.2.1 Global Semi-Solid Dose Annual Sales by Country/Region (2020-2025)
4.2.2 Global Semi-Solid Dose Annual Revenue by Country/Region (2020-2025)
4.3 Americas Semi-Solid Dose Sales Growth
4.4 APAC Semi-Solid Dose Sales Growth
4.5 Europe Semi-Solid Dose Sales Growth
4.6 Middle East & Africa Semi-Solid Dose Sales Growth
5 AMERICAS
5.1 Americas Semi-Solid Dose Sales by Country
5.1.1 Americas Semi-Solid Dose Sales by Country (2020-2025)
5.1.2 Americas Semi-Solid Dose Revenue by Country (2020-2025)
5.2 Americas Semi-Solid Dose Sales by Type (2020-2025)
5.3 Americas Semi-Solid Dose Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Semi-Solid Dose Sales by Region
6.1.1 APAC Semi-Solid Dose Sales by Region (2020-2025)
6.1.2 APAC Semi-Solid Dose Revenue by Region (2020-2025)
6.2 APAC Semi-Solid Dose Sales by Type (2020-2025)
6.3 APAC Semi-Solid Dose Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Semi-Solid Dose by Country
7.1.1 Europe Semi-Solid Dose Sales by Country (2020-2025)
7.1.2 Europe Semi-Solid Dose Revenue by Country (2020-2025)
7.2 Europe Semi-Solid Dose Sales by Type (2020-2025)
7.3 Europe Semi-Solid Dose Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Semi-Solid Dose by Country
8.1.1 Middle East & Africa Semi-Solid Dose Sales by Country (2020-2025)
8.1.2 Middle East & Africa Semi-Solid Dose Revenue by Country (2020-2025)
8.2 Middle East & Africa Semi-Solid Dose Sales by Type (2020-2025)
8.3 Middle East & Africa Semi-Solid Dose Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Semi-Solid Dose
10.3 Manufacturing Process Analysis of Semi-Solid Dose
10.4 Industry Chain Structure of Semi-Solid Dose
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Semi-Solid Dose Distributors
11.3 Semi-Solid Dose Customer
12 WORLD FORECAST REVIEW FOR SEMI-SOLID DOSE BY GEOGRAPHIC REGION
12.1 Global Semi-Solid Dose Market Size Forecast by Region
12.1.1 Global Semi-Solid Dose Forecast by Region (2026-2031)
12.1.2 Global Semi-Solid Dose Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Semi-Solid Dose Forecast by Type (2026-2031)
12.7 Global Semi-Solid Dose Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Semi-Solid Dose Product Portfolios and Specifications
13.1.3 Johnson & Johnson Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Merck & Co
13.2.1 Merck & Co Company Information
13.2.2 Merck & Co Semi-Solid Dose Product Portfolios and Specifications
13.2.3 Merck & Co Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck & Co Main Business Overview
13.2.5 Merck & Co Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Semi-Solid Dose Product Portfolios and Specifications
13.3.3 Bayer AG Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Hisamitsu Pharmaceutical
13.4.1 Hisamitsu Pharmaceutical Company Information
13.4.2 Hisamitsu Pharmaceutical Semi-Solid Dose Product Portfolios and Specifications
13.4.3 Hisamitsu Pharmaceutical Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Hisamitsu Pharmaceutical Main Business Overview
13.4.5 Hisamitsu Pharmaceutical Latest Developments
13.5 Glenmark Pharmaceuticals
13.5.1 Glenmark Pharmaceuticals Company Information
13.5.2 Glenmark Pharmaceuticals Semi-Solid Dose Product Portfolios and Specifications
13.5.3 Glenmark Pharmaceuticals Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Glenmark Pharmaceuticals Main Business Overview
13.5.5 Glenmark Pharmaceuticals Latest Developments
13.6 Cipla Ltd
13.6.1 Cipla Ltd Company Information
13.6.2 Cipla Ltd Semi-Solid Dose Product Portfolios and Specifications
13.6.3 Cipla Ltd Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Cipla Ltd Main Business Overview
13.6.5 Cipla Ltd Latest Developments
13.7 Nestle SA
13.7.1 Nestle SA Company Information
13.7.2 Nestle SA Semi-Solid Dose Product Portfolios and Specifications
13.7.3 Nestle SA Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nestle SA Main Business Overview
13.7.5 Nestle SA Latest Developments
13.8 Novartis AG
13.8.1 Novartis AG Company Information
13.8.2 Novartis AG Semi-Solid Dose Product Portfolios and Specifications
13.8.3 Novartis AG Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Novartis AG Main Business Overview
13.8.5 Novartis AG Latest Developments
13.9 GlaxoSmithKline plc
13.9.1 GlaxoSmithKline plc Company Information
13.9.2 GlaxoSmithKline plc Semi-Solid Dose Product Portfolios and Specifications
13.9.3 GlaxoSmithKline plc Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GlaxoSmithKline plc Main Business Overview
13.9.5 GlaxoSmithKline plc Latest Developments
13.10 Bausch Health Companies
13.10.1 Bausch Health Companies Company Information
13.10.2 Bausch Health Companies Semi-Solid Dose Product Portfolios and Specifications
13.10.3 Bausch Health Companies Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bausch Health Companies Main Business Overview
13.10.5 Bausch Health Companies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Semi-Solid Dose Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Semi-Solid Dose by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Semi-Solid Dose by Country/Region, 2020, 2024 & 2031
2.2 Semi-Solid Dose Segment by Type
2.2.1 Ointments
2.2.2 Pastes
2.2.3 Gels
2.3 Semi-Solid Dose Sales by Type
2.3.1 Global Semi-Solid Dose Sales Market Share by Type (2020-2025)
2.3.2 Global Semi-Solid Dose Revenue and Market Share by Type (2020-2025)
2.3.3 Global Semi-Solid Dose Sale Price by Type (2020-2025)
2.4 Semi-Solid Dose Segment by Application
2.4.1 Skin
2.4.2 Nasal Cavity
2.4.3 Vaginal Cavity
2.4.4 Rectal Cavity
2.4.5 Others
2.5 Semi-Solid Dose Sales by Application
2.5.1 Global Semi-Solid Dose Sale Market Share by Application (2020-2025)
2.5.2 Global Semi-Solid Dose Revenue and Market Share by Application (2020-2025)
2.5.3 Global Semi-Solid Dose Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Semi-Solid Dose Breakdown Data by Company
3.1.1 Global Semi-Solid Dose Annual Sales by Company (2020-2025)
3.1.2 Global Semi-Solid Dose Sales Market Share by Company (2020-2025)
3.2 Global Semi-Solid Dose Annual Revenue by Company (2020-2025)
3.2.1 Global Semi-Solid Dose Revenue by Company (2020-2025)
3.2.2 Global Semi-Solid Dose Revenue Market Share by Company (2020-2025)
3.3 Global Semi-Solid Dose Sale Price by Company
3.4 Key Manufacturers Semi-Solid Dose Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Semi-Solid Dose Product Location Distribution
3.4.2 Players Semi-Solid Dose Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SEMI-SOLID DOSE BY GEOGRAPHIC REGION
4.1 World Historic Semi-Solid Dose Market Size by Geographic Region (2020-2025)
4.1.1 Global Semi-Solid Dose Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Semi-Solid Dose Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Semi-Solid Dose Market Size by Country/Region (2020-2025)
4.2.1 Global Semi-Solid Dose Annual Sales by Country/Region (2020-2025)
4.2.2 Global Semi-Solid Dose Annual Revenue by Country/Region (2020-2025)
4.3 Americas Semi-Solid Dose Sales Growth
4.4 APAC Semi-Solid Dose Sales Growth
4.5 Europe Semi-Solid Dose Sales Growth
4.6 Middle East & Africa Semi-Solid Dose Sales Growth
5 AMERICAS
5.1 Americas Semi-Solid Dose Sales by Country
5.1.1 Americas Semi-Solid Dose Sales by Country (2020-2025)
5.1.2 Americas Semi-Solid Dose Revenue by Country (2020-2025)
5.2 Americas Semi-Solid Dose Sales by Type (2020-2025)
5.3 Americas Semi-Solid Dose Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Semi-Solid Dose Sales by Region
6.1.1 APAC Semi-Solid Dose Sales by Region (2020-2025)
6.1.2 APAC Semi-Solid Dose Revenue by Region (2020-2025)
6.2 APAC Semi-Solid Dose Sales by Type (2020-2025)
6.3 APAC Semi-Solid Dose Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Semi-Solid Dose by Country
7.1.1 Europe Semi-Solid Dose Sales by Country (2020-2025)
7.1.2 Europe Semi-Solid Dose Revenue by Country (2020-2025)
7.2 Europe Semi-Solid Dose Sales by Type (2020-2025)
7.3 Europe Semi-Solid Dose Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Semi-Solid Dose by Country
8.1.1 Middle East & Africa Semi-Solid Dose Sales by Country (2020-2025)
8.1.2 Middle East & Africa Semi-Solid Dose Revenue by Country (2020-2025)
8.2 Middle East & Africa Semi-Solid Dose Sales by Type (2020-2025)
8.3 Middle East & Africa Semi-Solid Dose Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Semi-Solid Dose
10.3 Manufacturing Process Analysis of Semi-Solid Dose
10.4 Industry Chain Structure of Semi-Solid Dose
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Semi-Solid Dose Distributors
11.3 Semi-Solid Dose Customer
12 WORLD FORECAST REVIEW FOR SEMI-SOLID DOSE BY GEOGRAPHIC REGION
12.1 Global Semi-Solid Dose Market Size Forecast by Region
12.1.1 Global Semi-Solid Dose Forecast by Region (2026-2031)
12.1.2 Global Semi-Solid Dose Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Semi-Solid Dose Forecast by Type (2026-2031)
12.7 Global Semi-Solid Dose Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Semi-Solid Dose Product Portfolios and Specifications
13.1.3 Johnson & Johnson Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Merck & Co
13.2.1 Merck & Co Company Information
13.2.2 Merck & Co Semi-Solid Dose Product Portfolios and Specifications
13.2.3 Merck & Co Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck & Co Main Business Overview
13.2.5 Merck & Co Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Semi-Solid Dose Product Portfolios and Specifications
13.3.3 Bayer AG Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Hisamitsu Pharmaceutical
13.4.1 Hisamitsu Pharmaceutical Company Information
13.4.2 Hisamitsu Pharmaceutical Semi-Solid Dose Product Portfolios and Specifications
13.4.3 Hisamitsu Pharmaceutical Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Hisamitsu Pharmaceutical Main Business Overview
13.4.5 Hisamitsu Pharmaceutical Latest Developments
13.5 Glenmark Pharmaceuticals
13.5.1 Glenmark Pharmaceuticals Company Information
13.5.2 Glenmark Pharmaceuticals Semi-Solid Dose Product Portfolios and Specifications
13.5.3 Glenmark Pharmaceuticals Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Glenmark Pharmaceuticals Main Business Overview
13.5.5 Glenmark Pharmaceuticals Latest Developments
13.6 Cipla Ltd
13.6.1 Cipla Ltd Company Information
13.6.2 Cipla Ltd Semi-Solid Dose Product Portfolios and Specifications
13.6.3 Cipla Ltd Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Cipla Ltd Main Business Overview
13.6.5 Cipla Ltd Latest Developments
13.7 Nestle SA
13.7.1 Nestle SA Company Information
13.7.2 Nestle SA Semi-Solid Dose Product Portfolios and Specifications
13.7.3 Nestle SA Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nestle SA Main Business Overview
13.7.5 Nestle SA Latest Developments
13.8 Novartis AG
13.8.1 Novartis AG Company Information
13.8.2 Novartis AG Semi-Solid Dose Product Portfolios and Specifications
13.8.3 Novartis AG Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Novartis AG Main Business Overview
13.8.5 Novartis AG Latest Developments
13.9 GlaxoSmithKline plc
13.9.1 GlaxoSmithKline plc Company Information
13.9.2 GlaxoSmithKline plc Semi-Solid Dose Product Portfolios and Specifications
13.9.3 GlaxoSmithKline plc Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GlaxoSmithKline plc Main Business Overview
13.9.5 GlaxoSmithKline plc Latest Developments
13.10 Bausch Health Companies
13.10.1 Bausch Health Companies Company Information
13.10.2 Bausch Health Companies Semi-Solid Dose Product Portfolios and Specifications
13.10.3 Bausch Health Companies Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bausch Health Companies Main Business Overview
13.10.5 Bausch Health Companies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Semi-Solid Dose Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Semi-Solid Dose Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ointments
Table 4. Major Players of Pastes
Table 5. Major Players of Gels
Table 6. Global Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 7. Global Semi-Solid Dose Sales Market Share by Type (2020-2025)
Table 8. Global Semi-Solid Dose Revenue by Type (2020-2025) & ($ million)
Table 9. Global Semi-Solid Dose Revenue Market Share by Type (2020-2025)
Table 10. Global Semi-Solid Dose Sale Price by Type (2020-2025) & (US$/Ton)
Table 11. Global Semi-Solid Dose Sale by Application (2020-2025) & (Tons)
Table 12. Global Semi-Solid Dose Sale Market Share by Application (2020-2025)
Table 13. Global Semi-Solid Dose Revenue by Application (2020-2025) & ($ million)
Table 14. Global Semi-Solid Dose Revenue Market Share by Application (2020-2025)
Table 15. Global Semi-Solid Dose Sale Price by Application (2020-2025) & (US$/Ton)
Table 16. Global Semi-Solid Dose Sales by Company (2020-2025) & (Tons)
Table 17. Global Semi-Solid Dose Sales Market Share by Company (2020-2025)
Table 18. Global Semi-Solid Dose Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Semi-Solid Dose Revenue Market Share by Company (2020-2025)
Table 20. Global Semi-Solid Dose Sale Price by Company (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Semi-Solid Dose Producing Area Distribution and Sales Area
Table 22. Players Semi-Solid Dose Products Offered
Table 23. Semi-Solid Dose Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Semi-Solid Dose Sales by Geographic Region (2020-2025) & (Tons)
Table 27. Global Semi-Solid Dose Sales Market Share Geographic Region (2020-2025)
Table 28. Global Semi-Solid Dose Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Semi-Solid Dose Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Semi-Solid Dose Sales by Country/Region (2020-2025) & (Tons)
Table 31. Global Semi-Solid Dose Sales Market Share by Country/Region (2020-2025)
Table 32. Global Semi-Solid Dose Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Semi-Solid Dose Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Semi-Solid Dose Sales by Country (2020-2025) & (Tons)
Table 35. Americas Semi-Solid Dose Sales Market Share by Country (2020-2025)
Table 36. Americas Semi-Solid Dose Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 38. Americas Semi-Solid Dose Sales by Application (2020-2025) & (Tons)
Table 39. APAC Semi-Solid Dose Sales by Region (2020-2025) & (Tons)
Table 40. APAC Semi-Solid Dose Sales Market Share by Region (2020-2025)
Table 41. APAC Semi-Solid Dose Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 43. APAC Semi-Solid Dose Sales by Application (2020-2025) & (Tons)
Table 44. Europe Semi-Solid Dose Sales by Country (2020-2025) & (Tons)
Table 45. Europe Semi-Solid Dose Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 47. Europe Semi-Solid Dose Sales by Application (2020-2025) & (Tons)
Table 48. Middle East & Africa Semi-Solid Dose Sales by Country (2020-2025) & (Tons)
Table 49. Middle East & Africa Semi-Solid Dose Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 51. Middle East & Africa Semi-Solid Dose Sales by Application (2020-2025) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Semi-Solid Dose
Table 53. Key Market Challenges & Risks of Semi-Solid Dose
Table 54. Key Industry Trends of Semi-Solid Dose
Table 55. Semi-Solid Dose Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Semi-Solid Dose Distributors List
Table 58. Semi-Solid Dose Customer List
Table 59. Global Semi-Solid Dose Sales Forecast by Region (2026-2031) & (Tons)
Table 60. Global Semi-Solid Dose Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Semi-Solid Dose Sales Forecast by Country (2026-2031) & (Tons)
Table 62. Americas Semi-Solid Dose Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Semi-Solid Dose Sales Forecast by Region (2026-2031) & (Tons)
Table 64. APAC Semi-Solid Dose Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Semi-Solid Dose Sales Forecast by Country (2026-2031) & (Tons)
Table 66. Europe Semi-Solid Dose Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Semi-Solid Dose Sales Forecast by Country (2026-2031) & (Tons)
Table 68. Middle East & Africa Semi-Solid Dose Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Semi-Solid Dose Sales Forecast by Type (2026-2031) & (Tons)
Table 70. Global Semi-Solid Dose Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Semi-Solid Dose Sales Forecast by Application (2026-2031) & (Tons)
Table 72. Global Semi-Solid Dose Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Johnson & Johnson Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 74. Johnson & Johnson Semi-Solid Dose Product Portfolios and Specifications
Table 75. Johnson & Johnson Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Latest Developments
Table 78. Merck & Co Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck & Co Semi-Solid Dose Product Portfolios and Specifications
Table 80. Merck & Co Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 81. Merck & Co Main Business
Table 82. Merck & Co Latest Developments
Table 83. Bayer AG Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer AG Semi-Solid Dose Product Portfolios and Specifications
Table 85. Bayer AG Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 86. Bayer AG Main Business
Table 87. Bayer AG Latest Developments
Table 88. Hisamitsu Pharmaceutical Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 89. Hisamitsu Pharmaceutical Semi-Solid Dose Product Portfolios and Specifications
Table 90. Hisamitsu Pharmaceutical Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 91. Hisamitsu Pharmaceutical Main Business
Table 92. Hisamitsu Pharmaceutical Latest Developments
Table 93. Glenmark Pharmaceuticals Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 94. Glenmark Pharmaceuticals Semi-Solid Dose Product Portfolios and Specifications
Table 95. Glenmark Pharmaceuticals Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 96. Glenmark Pharmaceuticals Main Business
Table 97. Glenmark Pharmaceuticals Latest Developments
Table 98. Cipla Ltd Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 99. Cipla Ltd Semi-Solid Dose Product Portfolios and Specifications
Table 100. Cipla Ltd Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 101. Cipla Ltd Main Business
Table 102. Cipla Ltd Latest Developments
Table 103. Nestle SA Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 104. Nestle SA Semi-Solid Dose Product Portfolios and Specifications
Table 105. Nestle SA Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 106. Nestle SA Main Business
Table 107. Nestle SA Latest Developments
Table 108. Novartis AG Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 109. Novartis AG Semi-Solid Dose Product Portfolios and Specifications
Table 110. Novartis AG Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 111. Novartis AG Main Business
Table 112. Novartis AG Latest Developments
Table 113. GlaxoSmithKline plc Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline plc Semi-Solid Dose Product Portfolios and Specifications
Table 115. GlaxoSmithKline plc Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 116. GlaxoSmithKline plc Main Business
Table 117. GlaxoSmithKline plc Latest Developments
Table 118. Bausch Health Companies Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 119. Bausch Health Companies Semi-Solid Dose Product Portfolios and Specifications
Table 120. Bausch Health Companies Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 121. Bausch Health Companies Main Business
Table 122. Bausch Health Companies Latest Developments
Table 1. Semi-Solid Dose Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Semi-Solid Dose Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ointments
Table 4. Major Players of Pastes
Table 5. Major Players of Gels
Table 6. Global Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 7. Global Semi-Solid Dose Sales Market Share by Type (2020-2025)
Table 8. Global Semi-Solid Dose Revenue by Type (2020-2025) & ($ million)
Table 9. Global Semi-Solid Dose Revenue Market Share by Type (2020-2025)
Table 10. Global Semi-Solid Dose Sale Price by Type (2020-2025) & (US$/Ton)
Table 11. Global Semi-Solid Dose Sale by Application (2020-2025) & (Tons)
Table 12. Global Semi-Solid Dose Sale Market Share by Application (2020-2025)
Table 13. Global Semi-Solid Dose Revenue by Application (2020-2025) & ($ million)
Table 14. Global Semi-Solid Dose Revenue Market Share by Application (2020-2025)
Table 15. Global Semi-Solid Dose Sale Price by Application (2020-2025) & (US$/Ton)
Table 16. Global Semi-Solid Dose Sales by Company (2020-2025) & (Tons)
Table 17. Global Semi-Solid Dose Sales Market Share by Company (2020-2025)
Table 18. Global Semi-Solid Dose Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Semi-Solid Dose Revenue Market Share by Company (2020-2025)
Table 20. Global Semi-Solid Dose Sale Price by Company (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Semi-Solid Dose Producing Area Distribution and Sales Area
Table 22. Players Semi-Solid Dose Products Offered
Table 23. Semi-Solid Dose Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Semi-Solid Dose Sales by Geographic Region (2020-2025) & (Tons)
Table 27. Global Semi-Solid Dose Sales Market Share Geographic Region (2020-2025)
Table 28. Global Semi-Solid Dose Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Semi-Solid Dose Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Semi-Solid Dose Sales by Country/Region (2020-2025) & (Tons)
Table 31. Global Semi-Solid Dose Sales Market Share by Country/Region (2020-2025)
Table 32. Global Semi-Solid Dose Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Semi-Solid Dose Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Semi-Solid Dose Sales by Country (2020-2025) & (Tons)
Table 35. Americas Semi-Solid Dose Sales Market Share by Country (2020-2025)
Table 36. Americas Semi-Solid Dose Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 38. Americas Semi-Solid Dose Sales by Application (2020-2025) & (Tons)
Table 39. APAC Semi-Solid Dose Sales by Region (2020-2025) & (Tons)
Table 40. APAC Semi-Solid Dose Sales Market Share by Region (2020-2025)
Table 41. APAC Semi-Solid Dose Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 43. APAC Semi-Solid Dose Sales by Application (2020-2025) & (Tons)
Table 44. Europe Semi-Solid Dose Sales by Country (2020-2025) & (Tons)
Table 45. Europe Semi-Solid Dose Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 47. Europe Semi-Solid Dose Sales by Application (2020-2025) & (Tons)
Table 48. Middle East & Africa Semi-Solid Dose Sales by Country (2020-2025) & (Tons)
Table 49. Middle East & Africa Semi-Solid Dose Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Semi-Solid Dose Sales by Type (2020-2025) & (Tons)
Table 51. Middle East & Africa Semi-Solid Dose Sales by Application (2020-2025) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Semi-Solid Dose
Table 53. Key Market Challenges & Risks of Semi-Solid Dose
Table 54. Key Industry Trends of Semi-Solid Dose
Table 55. Semi-Solid Dose Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Semi-Solid Dose Distributors List
Table 58. Semi-Solid Dose Customer List
Table 59. Global Semi-Solid Dose Sales Forecast by Region (2026-2031) & (Tons)
Table 60. Global Semi-Solid Dose Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Semi-Solid Dose Sales Forecast by Country (2026-2031) & (Tons)
Table 62. Americas Semi-Solid Dose Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Semi-Solid Dose Sales Forecast by Region (2026-2031) & (Tons)
Table 64. APAC Semi-Solid Dose Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Semi-Solid Dose Sales Forecast by Country (2026-2031) & (Tons)
Table 66. Europe Semi-Solid Dose Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Semi-Solid Dose Sales Forecast by Country (2026-2031) & (Tons)
Table 68. Middle East & Africa Semi-Solid Dose Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Semi-Solid Dose Sales Forecast by Type (2026-2031) & (Tons)
Table 70. Global Semi-Solid Dose Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Semi-Solid Dose Sales Forecast by Application (2026-2031) & (Tons)
Table 72. Global Semi-Solid Dose Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Johnson & Johnson Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 74. Johnson & Johnson Semi-Solid Dose Product Portfolios and Specifications
Table 75. Johnson & Johnson Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Latest Developments
Table 78. Merck & Co Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck & Co Semi-Solid Dose Product Portfolios and Specifications
Table 80. Merck & Co Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 81. Merck & Co Main Business
Table 82. Merck & Co Latest Developments
Table 83. Bayer AG Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer AG Semi-Solid Dose Product Portfolios and Specifications
Table 85. Bayer AG Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 86. Bayer AG Main Business
Table 87. Bayer AG Latest Developments
Table 88. Hisamitsu Pharmaceutical Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 89. Hisamitsu Pharmaceutical Semi-Solid Dose Product Portfolios and Specifications
Table 90. Hisamitsu Pharmaceutical Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 91. Hisamitsu Pharmaceutical Main Business
Table 92. Hisamitsu Pharmaceutical Latest Developments
Table 93. Glenmark Pharmaceuticals Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 94. Glenmark Pharmaceuticals Semi-Solid Dose Product Portfolios and Specifications
Table 95. Glenmark Pharmaceuticals Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 96. Glenmark Pharmaceuticals Main Business
Table 97. Glenmark Pharmaceuticals Latest Developments
Table 98. Cipla Ltd Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 99. Cipla Ltd Semi-Solid Dose Product Portfolios and Specifications
Table 100. Cipla Ltd Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 101. Cipla Ltd Main Business
Table 102. Cipla Ltd Latest Developments
Table 103. Nestle SA Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 104. Nestle SA Semi-Solid Dose Product Portfolios and Specifications
Table 105. Nestle SA Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 106. Nestle SA Main Business
Table 107. Nestle SA Latest Developments
Table 108. Novartis AG Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 109. Novartis AG Semi-Solid Dose Product Portfolios and Specifications
Table 110. Novartis AG Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 111. Novartis AG Main Business
Table 112. Novartis AG Latest Developments
Table 113. GlaxoSmithKline plc Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline plc Semi-Solid Dose Product Portfolios and Specifications
Table 115. GlaxoSmithKline plc Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 116. GlaxoSmithKline plc Main Business
Table 117. GlaxoSmithKline plc Latest Developments
Table 118. Bausch Health Companies Basic Information, Semi-Solid Dose Manufacturing Base, Sales Area and Its Competitors
Table 119. Bausch Health Companies Semi-Solid Dose Product Portfolios and Specifications
Table 120. Bausch Health Companies Semi-Solid Dose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 121. Bausch Health Companies Main Business
Table 122. Bausch Health Companies Latest Developments
LIST OF FIGURES
Figure 1. Picture of Semi-Solid Dose
Figure 2. Semi-Solid Dose Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Semi-Solid Dose Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Semi-Solid Dose Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Semi-Solid Dose Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Semi-Solid Dose Sales Market Share by Country/Region (2024)
Figure 10. Semi-Solid Dose Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Ointments
Figure 12. Product Picture of Pastes
Figure 13. Product Picture of Gels
Figure 14. Global Semi-Solid Dose Sales Market Share by Type in 2025
Figure 15. Global Semi-Solid Dose Revenue Market Share by Type (2020-2025)
Figure 16. Semi-Solid Dose Consumed in Skin
Figure 17. Global Semi-Solid Dose Market: Skin (2020-2025) & (Tons)
Figure 18. Semi-Solid Dose Consumed in Nasal Cavity
Figure 19. Global Semi-Solid Dose Market: Nasal Cavity (2020-2025) & (Tons)
Figure 20. Semi-Solid Dose Consumed in Vaginal Cavity
Figure 21. Global Semi-Solid Dose Market: Vaginal Cavity (2020-2025) & (Tons)
Figure 22. Semi-Solid Dose Consumed in Rectal Cavity
Figure 23. Global Semi-Solid Dose Market: Rectal Cavity (2020-2025) & (Tons)
Figure 24. Semi-Solid Dose Consumed in Others
Figure 25. Global Semi-Solid Dose Market: Others (2020-2025) & (Tons)
Figure 26. Global Semi-Solid Dose Sale Market Share by Application (2024)
Figure 27. Global Semi-Solid Dose Revenue Market Share by Application in 2025
Figure 28. Semi-Solid Dose Sales by Company in 2025 (Tons)
Figure 29. Global Semi-Solid Dose Sales Market Share by Company in 2025
Figure 30. Semi-Solid Dose Revenue by Company in 2025 ($ millions)
Figure 31. Global Semi-Solid Dose Revenue Market Share by Company in 2025
Figure 32. Global Semi-Solid Dose Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Semi-Solid Dose Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Semi-Solid Dose Sales 2020-2025 (Tons)
Figure 35. Americas Semi-Solid Dose Revenue 2020-2025 ($ millions)
Figure 36. APAC Semi-Solid Dose Sales 2020-2025 (Tons)
Figure 37. APAC Semi-Solid Dose Revenue 2020-2025 ($ millions)
Figure 38. Europe Semi-Solid Dose Sales 2020-2025 (Tons)
Figure 39. Europe Semi-Solid Dose Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Semi-Solid Dose Sales 2020-2025 (Tons)
Figure 41. Middle East & Africa Semi-Solid Dose Revenue 2020-2025 ($ millions)
Figure 42. Americas Semi-Solid Dose Sales Market Share by Country in 2025
Figure 43. Americas Semi-Solid Dose Revenue Market Share by Country (2020-2025)
Figure 44. Americas Semi-Solid Dose Sales Market Share by Type (2020-2025)
Figure 45. Americas Semi-Solid Dose Sales Market Share by Application (2020-2025)
Figure 46. United States Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Semi-Solid Dose Sales Market Share by Region in 2025
Figure 51. APAC Semi-Solid Dose Revenue Market Share by Region (2020-2025)
Figure 52. APAC Semi-Solid Dose Sales Market Share by Type (2020-2025)
Figure 53. APAC Semi-Solid Dose Sales Market Share by Application (2020-2025)
Figure 54. China Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 58. India Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Semi-Solid Dose Sales Market Share by Country in 2025
Figure 62. Europe Semi-Solid Dose Revenue Market Share by Country (2020-2025)
Figure 63. Europe Semi-Solid Dose Sales Market Share by Type (2020-2025)
Figure 64. Europe Semi-Solid Dose Sales Market Share by Application (2020-2025)
Figure 65. Germany Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 66. France Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Semi-Solid Dose Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Semi-Solid Dose Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Semi-Solid Dose Sales Market Share by Application (2020-2025)
Figure 73. Egypt Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Semi-Solid Dose in 2025
Figure 79. Manufacturing Process Analysis of Semi-Solid Dose
Figure 80. Industry Chain Structure of Semi-Solid Dose
Figure 81. Channels of Distribution
Figure 82. Global Semi-Solid Dose Sales Market Forecast by Region (2026-2031)
Figure 83. Global Semi-Solid Dose Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Semi-Solid Dose Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Semi-Solid Dose Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Semi-Solid Dose Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Semi-Solid Dose Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Semi-Solid Dose
Figure 2. Semi-Solid Dose Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Semi-Solid Dose Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Semi-Solid Dose Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Semi-Solid Dose Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Semi-Solid Dose Sales Market Share by Country/Region (2024)
Figure 10. Semi-Solid Dose Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Ointments
Figure 12. Product Picture of Pastes
Figure 13. Product Picture of Gels
Figure 14. Global Semi-Solid Dose Sales Market Share by Type in 2025
Figure 15. Global Semi-Solid Dose Revenue Market Share by Type (2020-2025)
Figure 16. Semi-Solid Dose Consumed in Skin
Figure 17. Global Semi-Solid Dose Market: Skin (2020-2025) & (Tons)
Figure 18. Semi-Solid Dose Consumed in Nasal Cavity
Figure 19. Global Semi-Solid Dose Market: Nasal Cavity (2020-2025) & (Tons)
Figure 20. Semi-Solid Dose Consumed in Vaginal Cavity
Figure 21. Global Semi-Solid Dose Market: Vaginal Cavity (2020-2025) & (Tons)
Figure 22. Semi-Solid Dose Consumed in Rectal Cavity
Figure 23. Global Semi-Solid Dose Market: Rectal Cavity (2020-2025) & (Tons)
Figure 24. Semi-Solid Dose Consumed in Others
Figure 25. Global Semi-Solid Dose Market: Others (2020-2025) & (Tons)
Figure 26. Global Semi-Solid Dose Sale Market Share by Application (2024)
Figure 27. Global Semi-Solid Dose Revenue Market Share by Application in 2025
Figure 28. Semi-Solid Dose Sales by Company in 2025 (Tons)
Figure 29. Global Semi-Solid Dose Sales Market Share by Company in 2025
Figure 30. Semi-Solid Dose Revenue by Company in 2025 ($ millions)
Figure 31. Global Semi-Solid Dose Revenue Market Share by Company in 2025
Figure 32. Global Semi-Solid Dose Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Semi-Solid Dose Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Semi-Solid Dose Sales 2020-2025 (Tons)
Figure 35. Americas Semi-Solid Dose Revenue 2020-2025 ($ millions)
Figure 36. APAC Semi-Solid Dose Sales 2020-2025 (Tons)
Figure 37. APAC Semi-Solid Dose Revenue 2020-2025 ($ millions)
Figure 38. Europe Semi-Solid Dose Sales 2020-2025 (Tons)
Figure 39. Europe Semi-Solid Dose Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Semi-Solid Dose Sales 2020-2025 (Tons)
Figure 41. Middle East & Africa Semi-Solid Dose Revenue 2020-2025 ($ millions)
Figure 42. Americas Semi-Solid Dose Sales Market Share by Country in 2025
Figure 43. Americas Semi-Solid Dose Revenue Market Share by Country (2020-2025)
Figure 44. Americas Semi-Solid Dose Sales Market Share by Type (2020-2025)
Figure 45. Americas Semi-Solid Dose Sales Market Share by Application (2020-2025)
Figure 46. United States Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Semi-Solid Dose Sales Market Share by Region in 2025
Figure 51. APAC Semi-Solid Dose Revenue Market Share by Region (2020-2025)
Figure 52. APAC Semi-Solid Dose Sales Market Share by Type (2020-2025)
Figure 53. APAC Semi-Solid Dose Sales Market Share by Application (2020-2025)
Figure 54. China Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 58. India Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Semi-Solid Dose Sales Market Share by Country in 2025
Figure 62. Europe Semi-Solid Dose Revenue Market Share by Country (2020-2025)
Figure 63. Europe Semi-Solid Dose Sales Market Share by Type (2020-2025)
Figure 64. Europe Semi-Solid Dose Sales Market Share by Application (2020-2025)
Figure 65. Germany Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 66. France Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Semi-Solid Dose Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Semi-Solid Dose Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Semi-Solid Dose Sales Market Share by Application (2020-2025)
Figure 73. Egypt Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Semi-Solid Dose Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Semi-Solid Dose in 2025
Figure 79. Manufacturing Process Analysis of Semi-Solid Dose
Figure 80. Industry Chain Structure of Semi-Solid Dose
Figure 81. Channels of Distribution
Figure 82. Global Semi-Solid Dose Sales Market Forecast by Region (2026-2031)
Figure 83. Global Semi-Solid Dose Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Semi-Solid Dose Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Semi-Solid Dose Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Semi-Solid Dose Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Semi-Solid Dose Revenue Market Share Forecast by Application (2026-2031)
